 | • レポートコード：MRC2-11QY03957 • 出版社/出版日：QYResearch / 2020年11月20日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、97ページ • 納品方法：Eメール（納期：2~3日） • 産業分類：ヘルスケア |
| Single User | ￥585,000 (USD3,900) | ▷ お問い合わせ |
| Multi User | ￥877,500 (USD5,850) | ▷ お問い合わせ |
| Enterprise License | ￥1,170,000 (USD7,800) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 当調査資料は神経精神障害・治療のグローバル市場について調査・分析したレポートです。種類別（変性疾患、神経症、精神病）市場規模、用途別（病院、診療所、研究センター）市場規模、地域別（北米、米国、カナダ、ヨーロッパ、ドイツ、フランス、イギリス、イタリア、ロシア、アジア、日本、中国、韓国、インド、オーストラリア、台湾、中南米、メキシコ、ブラジル、アルゼンチン、中東・アフリカ、トルコ、サウジアラビア、UAE等）市場規模データ、主な企業情報と企業別市場シェア等が収録されています。 ・調査範囲 ・エグゼクティブサマリー ・企業別神経精神障害・治療の競争状況、市場シェア ・世界の神経精神障害・治療市場：種類別市場規模 2015年-2020年（変性疾患、神経症、精神病） ・世界の神経精神障害・治療市場：種類別市場規模予測 2021年-2026年（変性疾患、神経症、精神病） ・世界の神経精神障害・治療市場：用途別市場規模 2015年-2020年（病院、診療所、研究センター） ・世界の神経精神障害・治療市場：用途別市場規模予測 2021年-2026年（病院、診療所、研究センター） ・北米の神経精神障害・治療市場分析：米国、カナダ ・ヨーロッパの神経精神障害・治療市場分析：ドイツ、フランス、イギリス、イタリア、ロシア等 ・アジアの神経精神障害・治療市場分析：日本、中国、韓国、インド、オーストラリア、台湾等 ・中南米の神経精神障害・治療市場分析：メキシコ、ブラジル、アルゼンチン等 ・中東・アフリカの神経精神障害・治療市場分析：トルコ、サウジアラビア、UAE等 ・企業情報（企業概要、製品概要、販売量、企業動向） - 掲載企業（変更可能性あり）：Astrazeneca、Glaxosmithkline、Universal Health Services、Boehringer Ingelheim、Eli Lilly ・地域別市場規模予測（2021年-2026年）：北米市場、ヨーロッパ市場、アジア市場、中南米市場、中東・アフリカ市場 ・市場機会、課題、リスク、環境分析 ・バリューチェーン、販売チャネル分析 ・調査の結論 |
Neuropsychiatric disorder is a blanket medical term that encompasses a broad range of medical conditions that involve both neurology and psychiatry. Common neuropsychiatric disorders include seizures, attention deficits, cognitive deficits, palsies, uncontrolled anger, migraine headaches, addictions, eating disorders, depression, and anxiety and others. They can range widely in cause, course, and severity.
The key component of neuropsychiatric disorders is that the symptoms tend to impact brain function, emotion and mood. These can range from problems with focus and learning in the case of ADHD to sadness, irritability, memory problems, mood problems, depression to a variety of other psychiatric and/or neurological symptoms. Medications, psychological and/or psychiatric therapy are common treatments for neuropsychiatric disorders. Specific treatments will vary based on the precise cause, clinical presentation and severity.
Market Analysis and Insights: Global Neuropsychiatric Disorders And Treatment Market
The global Neuropsychiatric Disorders And Treatment market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX%% during 2021-2026.
Global Neuropsychiatric Disorders And Treatment Scope and Market Size
Neuropsychiatric Disorders And Treatment market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Neuropsychiatric Disorders And Treatment market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2015-2026.
The key players covered in this study
Astrazeneca
Glaxosmithkline
Universal Health Services
Boehringer Ingelheim
Eli Lilly
…
Market segment by Type, the product can be split into
Degenerative Diseases
Neurotic Disorders
Psychosis
Market segment by Application, split into
Hospitals
Clinics
Research Centres
Market segment by Regions/Countries, this report covers
North America
Europe
China
Japan
Southeast Asia
India
1 Report Overview
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered: Ranking by Neuropsychiatric Disorders And Treatment Revenue
1.4 Market by Type
1.4.1 Global Neuropsychiatric Disorders And Treatment Market Size Growth Rate by Type: 2020 VS 2026
1.4.2 Degenerative Diseases
1.4.3 Neurotic Disorders
1.4.4 Psychosis
1.5 Market by Application
1.5.1 Global Neuropsychiatric Disorders And Treatment Market Share by Application: 2020 VS 2026
1.5.2 Hospitals
1.5.3 Clinics
1.5.4 Research Centres
1.6 Study Objectives
1.7 Years Considered
2 Global Growth Trends
2.1 Global Neuropsychiatric Disorders And Treatment Market Perspective (2015-2026)
2.2 Global Neuropsychiatric Disorders And Treatment Growth Trends by Regions
2.2.1 Neuropsychiatric Disorders And Treatment Market Size by Regions: 2015 VS 2020 VS 2026
2.2.2 Neuropsychiatric Disorders And Treatment Historic Market Share by Regions (2015-2020)
2.2.3 Neuropsychiatric Disorders And Treatment Forecasted Market Size by Regions (2021-2026)
2.3 Industry Trends and Growth Strategy
2.3.1 Market Top Trends
2.3.2 Market Drivers
2.3.3 Market Challenges
2.3.4 Porter’s Five Forces Analysis
2.3.5 Neuropsychiatric Disorders And Treatment Market Growth Strategy
2.3.6 Primary Interviews with Key Neuropsychiatric Disorders And Treatment Players (Opinion Leaders)
3 Competition Landscape by Key Players
3.1 Global Top Neuropsychiatric Disorders And Treatment Players by Market Size
3.1.1 Global Top Neuropsychiatric Disorders And Treatment Players by Revenue (2015-2020)
3.1.2 Global Neuropsychiatric Disorders And Treatment Revenue Market Share by Players (2015-2020)
3.1.3 Global Neuropsychiatric Disorders And Treatment Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.2 Global Neuropsychiatric Disorders And Treatment Market Concentration Ratio
3.2.1 Global Neuropsychiatric Disorders And Treatment Market Concentration Ratio (CR5 and HHI)
3.2.2 Global Top 10 and Top 5 Companies by Neuropsychiatric Disorders And Treatment Revenue in 2019
3.3 Neuropsychiatric Disorders And Treatment Key Players Head office and Area Served
3.4 Key Players Neuropsychiatric Disorders And Treatment Product Solution and Service
3.5 Date of Enter into Neuropsychiatric Disorders And Treatment Market
3.6 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type (2015-2026)
4.1 Global Neuropsychiatric Disorders And Treatment Historic Market Size by Type (2015-2020)
4.2 Global Neuropsychiatric Disorders And Treatment Forecasted Market Size by Type (2021-2026)
5 Market Size by Application (2015-2026)
5.1 Global Neuropsychiatric Disorders And Treatment Market Size by Application (2015-2020)
5.2 Global Neuropsychiatric Disorders And Treatment Forecasted Market Size by Application (2021-2026)
6 North America
6.1 North America Neuropsychiatric Disorders And Treatment Market Size (2015-2020)
6.2 Neuropsychiatric Disorders And Treatment Key Players in North America (2019-2020)
6.3 North America Neuropsychiatric Disorders And Treatment Market Size by Type (2015-2020)
6.4 North America Neuropsychiatric Disorders And Treatment Market Size by Application (2015-2020)
7 Europe
7.1 Europe Neuropsychiatric Disorders And Treatment Market Size (2015-2020)
7.2 Neuropsychiatric Disorders And Treatment Key Players in Europe (2019-2020)
7.3 Europe Neuropsychiatric Disorders And Treatment Market Size by Type (2015-2020)
7.4 Europe Neuropsychiatric Disorders And Treatment Market Size by Application (2015-2020)
8 China
8.1 China Neuropsychiatric Disorders And Treatment Market Size (2015-2020)
8.2 Neuropsychiatric Disorders And Treatment Key Players in China (2019-2020)
8.3 China Neuropsychiatric Disorders And Treatment Market Size by Type (2015-2020)
8.4 China Neuropsychiatric Disorders And Treatment Market Size by Application (2015-2020)
9 Japan
9.1 Japan Neuropsychiatric Disorders And Treatment Market Size (2015-2020)
9.2 Neuropsychiatric Disorders And Treatment Key Players in Japan (2019-2020)
9.3 Japan Neuropsychiatric Disorders And Treatment Market Size by Type (2015-2020)
9.4 Japan Neuropsychiatric Disorders And Treatment Market Size by Application (2015-2020)
10 Southeast Asia
10.1 Southeast Asia Neuropsychiatric Disorders And Treatment Market Size (2015-2020)
10.2 Neuropsychiatric Disorders And Treatment Key Players in Southeast Asia (2019-2020)
10.3 Southeast Asia Neuropsychiatric Disorders And Treatment Market Size by Type (2015-2020)
10.4 Southeast Asia Neuropsychiatric Disorders And Treatment Market Size by Application (2015-2020)
11 India
11.1 India Neuropsychiatric Disorders And Treatment Market Size (2015-2020)
11.2 Neuropsychiatric Disorders And Treatment Key Players in India (2019-2020)
11.3 India Neuropsychiatric Disorders And Treatment Market Size by Type (2015-2020)
11.4 India Neuropsychiatric Disorders And Treatment Market Size by Application (2015-2020)
12 Central & South America
12.1 Central & South America Neuropsychiatric Disorders And Treatment Market Size (2015-2020)
12.2 Neuropsychiatric Disorders And Treatment Key Players in Central & South America (2019-2020)
12.3 Central & South America Neuropsychiatric Disorders And Treatment Market Size by Type (2015-2020)
12.4 Central & South America Neuropsychiatric Disorders And Treatment Market Size by Application (2015-2020)
13 Key Players Profiles
13.1 Astrazeneca
13.1.1 Astrazeneca Company Details
13.1.2 Astrazeneca Business Overview
13.1.3 Astrazeneca Neuropsychiatric Disorders And Treatment Introduction
13.1.4 Astrazeneca Revenue in Neuropsychiatric Disorders And Treatment Business (2015-2020))
13.1.5 Astrazeneca Recent Development
13.2 Glaxosmithkline
13.2.1 Glaxosmithkline Company Details
13.2.2 Glaxosmithkline Business Overview
13.2.3 Glaxosmithkline Neuropsychiatric Disorders And Treatment Introduction
13.2.4 Glaxosmithkline Revenue in Neuropsychiatric Disorders And Treatment Business (2015-2020)
13.2.5 Glaxosmithkline Recent Development
13.3 Universal Health Services
13.3.1 Universal Health Services Company Details
13.3.2 Universal Health Services Business Overview
13.3.3 Universal Health Services Neuropsychiatric Disorders And Treatment Introduction
13.3.4 Universal Health Services Revenue in Neuropsychiatric Disorders And Treatment Business (2015-2020)
13.3.5 Universal Health Services Recent Development
13.4 Boehringer Ingelheim
13.4.1 Boehringer Ingelheim Company Details
13.4.2 Boehringer Ingelheim Business Overview
13.4.3 Boehringer Ingelheim Neuropsychiatric Disorders And Treatment Introduction
13.4.4 Boehringer Ingelheim Revenue in Neuropsychiatric Disorders And Treatment Business (2015-2020)
13.4.5 Boehringer Ingelheim Recent Development
13.5 Eli Lilly
13.5.1 Eli Lilly Company Details
13.5.2 Eli Lilly Business Overview
13.5.3 Eli Lilly Neuropsychiatric Disorders And Treatment Introduction
13.5.4 Eli Lilly Revenue in Neuropsychiatric Disorders And Treatment Business (2015-2020)
13.5.5 Eli Lilly Recent Development
14 Analyst’s Viewpoints/Conclusions
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Disclaimer
15.3 Author Details
Table 1. Neuropsychiatric Disorders And Treatment Key Market Segments
Table 2. Key Players Covered: Ranking by Neuropsychiatric Disorders And Treatment Revenue
Table 3. Ranking of Global Top Neuropsychiatric Disorders And Treatment Manufacturers by Revenue (US$ Million) in 2019
Table 4. Global Neuropsychiatric Disorders And Treatment Market Size Growth Rate by Type (US$ Million): 2020 VS 2026
Table 5. Key Players of Degenerative Diseases
Table 6. Key Players of Neurotic Disorders
Table 7. Key Players of Psychosis
Table 8. Global Neuropsychiatric Disorders And Treatment Market Size Growth by Application (US$ Million): 2020 VS 2026
Table 9. Global Neuropsychiatric Disorders And Treatment Market Size by Regions (US$ Million): 2020 VS 2026
Table 10. Global Neuropsychiatric Disorders And Treatment Market Size by Regions (2015-2020) (US$ Million)
Table 11. Global Neuropsychiatric Disorders And Treatment Market Share by Regions (2015-2020)
Table 12. Global Neuropsychiatric Disorders And Treatment Forecasted Market Size by Regions (2021-2026) (US$ Million)
Table 13. Global Neuropsychiatric Disorders And Treatment Market Share by Regions (2021-2026)
Table 14. Market Top Trends
Table 15. Key Drivers: Impact Analysis
Table 16. Key Challenges
Table 17. Neuropsychiatric Disorders And Treatment Market Growth Strategy
Table 18. Main Points Interviewed from Key Neuropsychiatric Disorders And Treatment Players
Table 19. Global Neuropsychiatric Disorders And Treatment Revenue by Players (2015-2020) (Million US$)
Table 20. Global Neuropsychiatric Disorders And Treatment Market Share by Players (2015-2020)
Table 21. Global Top Neuropsychiatric Disorders And Treatment Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Neuropsychiatric Disorders And Treatment as of 2019)
Table 22. Global Neuropsychiatric Disorders And Treatment by Players Market Concentration Ratio (CR5 and HHI)
Table 23. Key Players Headquarters and Area Served
Table 24. Key Players Neuropsychiatric Disorders And Treatment Product Solution and Service
Table 25. Date of Enter into Neuropsychiatric Disorders And Treatment Market
Table 26. Mergers & Acquisitions, Expansion Plans
Table 27. Global Neuropsychiatric Disorders And Treatment Market Size by Type (2015-2020) (Million US$)
Table 28. Global Neuropsychiatric Disorders And Treatment Market Size Share by Type (2015-2020)
Table 29. Global Neuropsychiatric Disorders And Treatment Revenue Market Share by Type (2021-2026)
Table 30. Global Neuropsychiatric Disorders And Treatment Market Size Share by Application (2015-2020)
Table 31. Global Neuropsychiatric Disorders And Treatment Market Size by Application (2015-2020) (Million US$)
Table 32. Global Neuropsychiatric Disorders And Treatment Market Size Share by Application (2021-2026)
Table 33. North America Key Players Neuropsychiatric Disorders And Treatment Revenue (2019-2020) (Million US$)
Table 34. North America Key Players Neuropsychiatric Disorders And Treatment Market Share (2019-2020)
Table 35. North America Neuropsychiatric Disorders And Treatment Market Size by Type (2015-2020) (Million US$)
Table 36. North America Neuropsychiatric Disorders And Treatment Market Share by Type (2015-2020)
Table 37. North America Neuropsychiatric Disorders And Treatment Market Size by Application (2015-2020) (Million US$)
Table 38. North America Neuropsychiatric Disorders And Treatment Market Share by Application (2015-2020)
Table 39. Europe Key Players Neuropsychiatric Disorders And Treatment Revenue (2019-2020) (Million US$)
Table 40. Europe Key Players Neuropsychiatric Disorders And Treatment Market Share (2019-2020)
Table 41. Europe Neuropsychiatric Disorders And Treatment Market Size by Type (2015-2020) (Million US$)
Table 42. Europe Neuropsychiatric Disorders And Treatment Market Share by Type (2015-2020)
Table 43. Europe Neuropsychiatric Disorders And Treatment Market Size by Application (2015-2020) (Million US$)
Table 44. Europe Neuropsychiatric Disorders And Treatment Market Share by Application (2015-2020)
Table 45. China Key Players Neuropsychiatric Disorders And Treatment Revenue (2019-2020) (Million US$)
Table 46. China Key Players Neuropsychiatric Disorders And Treatment Market Share (2019-2020)
Table 47. China Neuropsychiatric Disorders And Treatment Market Size by Type (2015-2020) (Million US$)
Table 48. China Neuropsychiatric Disorders And Treatment Market Share by Type (2015-2020)
Table 49. China Neuropsychiatric Disorders And Treatment Market Size by Application (2015-2020) (Million US$)
Table 50. China Neuropsychiatric Disorders And Treatment Market Share by Application (2015-2020)
Table 51. Japan Key Players Neuropsychiatric Disorders And Treatment Revenue (2019-2020) (Million US$)
Table 52. Japan Key Players Neuropsychiatric Disorders And Treatment Market Share (2019-2020)
Table 53. Japan Neuropsychiatric Disorders And Treatment Market Size by Type (2015-2020) (Million US$)
Table 54. Japan Neuropsychiatric Disorders And Treatment Market Share by Type (2015-2020)
Table 55. Japan Neuropsychiatric Disorders And Treatment Market Size by Application (2015-2020) (Million US$)
Table 56. Japan Neuropsychiatric Disorders And Treatment Market Share by Application (2015-2020)
Table 57. Southeast Asia Key Players Neuropsychiatric Disorders And Treatment Revenue (2019-2020) (Million US$)
Table 58. Southeast Asia Key Players Neuropsychiatric Disorders And Treatment Market Share (2019-2020)
Table 59. Southeast Asia Neuropsychiatric Disorders And Treatment Market Size by Type (2015-2020) (Million US$)
Table 60. Southeast Asia Neuropsychiatric Disorders And Treatment Market Share by Type (2015-2020)
Table 61. Southeast Asia Neuropsychiatric Disorders And Treatment Market Size by Application (2015-2020) (Million US$)
Table 62. Southeast Asia Neuropsychiatric Disorders And Treatment Market Share by Application (2015-2020)
Table 63. India Key Players Neuropsychiatric Disorders And Treatment Revenue (2019-2020) (Million US$)
Table 64. India Key Players Neuropsychiatric Disorders And Treatment Market Share (2019-2020)
Table 65. India Neuropsychiatric Disorders And Treatment Market Size by Type (2015-2020) (Million US$)
Table 66. India Neuropsychiatric Disorders And Treatment Market Share by Type (2015-2020)
Table 67. India Neuropsychiatric Disorders And Treatment Market Size by Application (2015-2020) (Million US$)
Table 68. India Neuropsychiatric Disorders And Treatment Market Share by Application (2015-2020)
Table 69. Central & South America Key Players Neuropsychiatric Disorders And Treatment Revenue (2019-2020) (Million US$)
Table 70. Central & South America Key Players Neuropsychiatric Disorders And Treatment Market Share (2019-2020)
Table 71. Central & South America Neuropsychiatric Disorders And Treatment Market Size by Type (2015-2020) (Million US$)
Table 72. Central & South America Neuropsychiatric Disorders And Treatment Market Share by Type (2015-2020)
Table 73. Central & South America Neuropsychiatric Disorders And Treatment Market Size by Application (2015-2020) (Million US$)
Table 74. Central & South America Neuropsychiatric Disorders And Treatment Market Share by Application (2015-2020)
Table 75. Astrazeneca Company Details
Table 76. Astrazeneca Business Overview
Table 77. Astrazeneca Product
Table 78. Astrazeneca Revenue in Neuropsychiatric Disorders And Treatment Business (2015-2020) (Million US$)
Table 79. Astrazeneca Recent Development
Table 80. Glaxosmithkline Company Details
Table 81. Glaxosmithkline Business Overview
Table 82. Glaxosmithkline Product
Table 83. Glaxosmithkline Revenue in Neuropsychiatric Disorders And Treatment Business (2015-2020) (Million US$)
Table 84. Glaxosmithkline Recent Development
Table 85. Universal Health Services Company Details
Table 86. Universal Health Services Business Overview
Table 87. Universal Health Services Product
Table 88. Universal Health Services Revenue in Neuropsychiatric Disorders And Treatment Business (2015-2020) (Million US$)
Table 89. Universal Health Services Recent Development
Table 90. Boehringer Ingelheim Company Details
Table 91. Boehringer Ingelheim Business Overview
Table 92. Boehringer Ingelheim Product
Table 93. Boehringer Ingelheim Revenue in Neuropsychiatric Disorders And Treatment Business (2015-2020) (Million US$)
Table 94. Boehringer Ingelheim Recent Development
Table 95. Eli Lilly Company Details
Table 96. Eli Lilly Business Overview
Table 97. Eli Lilly Product
Table 98. Eli Lilly Revenue in Neuropsychiatric Disorders And Treatment Business (2015-2020) (Million US$)
Table 99. Eli Lilly Recent Development
Table 100. Research Programs/Design for This Report
Table 101. Key Data Information from Secondary Sources
Table 102. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Neuropsychiatric Disorders And Treatment Market Share by Type: 2020 VS 2026
Figure 2. Degenerative Diseases Features
Figure 3. Neurotic Disorders Features
Figure 4. Psychosis Features
Figure 5. Global Neuropsychiatric Disorders And Treatment Market Share by Application: 2020 VS 2026
Figure 6. Hospitals Case Studies
Figure 7. Clinics Case Studies
Figure 8. Research Centres Case Studies
Figure 9. Neuropsychiatric Disorders And Treatment Report Years Considered
Figure 10. Global Neuropsychiatric Disorders And Treatment Market Size YoY Growth 2015-2026 (US$ Million)
Figure 11. Global Neuropsychiatric Disorders And Treatment Market Share by Regions: 2020 VS 2026
Figure 12. Global Neuropsychiatric Disorders And Treatment Market Share by Regions (2021-2026)
Figure 13. Porter's Five Forces Analysis
Figure 14. Global Neuropsychiatric Disorders And Treatment Market Share by Players in 2019
Figure 15. Global Top Neuropsychiatric Disorders And Treatment Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Neuropsychiatric Disorders And Treatment as of 2019
Figure 16. The Top 10 and 5 Players Market Share by Neuropsychiatric Disorders And Treatment Revenue in 2019
Figure 17. North America Neuropsychiatric Disorders And Treatment Market Size YoY Growth (2015-2020) (Million US$)
Figure 18. Europe Neuropsychiatric Disorders And Treatment Market Size YoY Growth (2015-2020) (Million US$)
Figure 19. China Neuropsychiatric Disorders And Treatment Market Size YoY Growth (2015-2020) (Million US$)
Figure 20. Japan Neuropsychiatric Disorders And Treatment Market Size YoY Growth (2015-2020) (Million US$)
Figure 21. Southeast Asia Neuropsychiatric Disorders And Treatment Market Size YoY Growth (2015-2020) (Million US$)
Figure 22. India Neuropsychiatric Disorders And Treatment Market Size YoY Growth (2015-2020) (Million US$)
Figure 23. Central & South America Neuropsychiatric Disorders And Treatment Market Size YoY Growth (2015-2020) (Million US$)
Figure 24. Bottom-up and Top-down Approaches for This Report
Figure 25. Data Triangulation
Figure 26. Key Executives Interviewed
骨・ミネラル代謝障害治療の世界市場（～2026年） Bone minerals are the inorganic compounds of the bone tissue that helps in strengthening the bones with its plate and globular structures. These minerals are formed from carbonated hydroxyapatite. Bone minerals are dynamic in living beings, it is continuously reabsorbed and build anew in the bone re…- アミノ酸代謝異常治療の世界市場（～2026年） Market Analysis and Insights: Global Amino Acid Metabolism Disorders Treatment Market The global Amino Acid Metabolism Disorders Treatment market size is projected to reach US$ 578.9 million by 2026, from US$ 547 million in 2020, at a CAGR of 5.3%% during 2021-2026. Global Amino Acid Metabolism Diso…
- 統合失調感情障害治療の世界市場（～2026年） Types of schizoaffective disorders include manic, depressive, mixed, and schizoaffective disorders. The regional market for schizoaffective affective disorders is very common in North America, Europe and Asia Pacific. Market Analysis and Insights: Global Schizoaffective Disorders Treatment Market Th…
- 不安障害・うつ病治療の世界市場（～2026年） Anxiety disorders and depression are treatable, and the vast majority of people can be helped with professional care. Often depression and an anxiety disorder can be treated similarly. In many cases, therapy can be tailored to an individual so that it works to reduce the symptoms of both disorders. …
- 膝・股関節障害の世界市場（～2026年） Knee and hip are complex joints in the body. The knee joins the thigh bone (femur) to the shin bone (tibia), whereas the hip joint is a ball-socket synovial joint formed between the os coxa (hip bone) and the femur. To treat knee and hip disorders, implants and surgeries are performed so as to keep …